Lv5
948 积分 2026-05-09 加入
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence
1个月前
已完结
Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma
1个月前
已完结
Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review
1个月前
已完结
Neoadjuvant therapy for pancreatic cancer
1个月前
已完结
The Role of Circulating Tumor DNA in Surgical Management of Pancreatic Cancer: Systematic Review and Meta-analysis
1个月前
已关闭
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9–Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment
1个月前
已完结
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma
1个月前
已完结
Surgery for Locally Advanced Pancreatic Cancer: Oncological Landmarks for Venous and Arterial Reconstruction
1个月前
已完结
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
1个月前
已完结
Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer
1个月前
已完结
皖公网安备34019202002308
